144 related articles for article (PubMed ID: 12037988)
1. Phosphatidylinositol 3-kinase, phosphoinositides and apoptosis. Polyphosphoinositol phosphatase and apoptosis.
Sarmay G
Subcell Biochem; 2002; 36():309-33. PubMed ID: 12037988
[No Abstract] [Full Text] [Related]
2. [Cytokine receptors and signal transduction].
Nakajima H; Kitamura T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():178-86. PubMed ID: 15861654
[No Abstract] [Full Text] [Related]
3. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
Sasaki T; Sasaki J; Suzuki A; Penninger JM
Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
[No Abstract] [Full Text] [Related]
4. Myotubularin phosphatases: policing 3-phosphoinositides.
Robinson FL; Dixon JE
Trends Cell Biol; 2006 Aug; 16(8):403-12. PubMed ID: 16828287
[TBL] [Abstract][Full Text] [Related]
5. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
6. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
Zhang S; Broxmeyer HE
Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
Sattler M; Salgia R; Shrikhande G; Verma S; Choi JL; Rohrschneider LR; Griffin JD
Oncogene; 1997 Nov; 15(19):2379-84. PubMed ID: 9393882
[TBL] [Abstract][Full Text] [Related]
8. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
[TBL] [Abstract][Full Text] [Related]
9. Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase.
Liu Y; Jenkins B; Shin JL; Rohrschneider LR
Mol Cell Biol; 2001 May; 21(9):3047-56. PubMed ID: 11287610
[TBL] [Abstract][Full Text] [Related]
10. Negative signaling.
Coggeshall KM
Mol Immunol; 2002 Dec; 39(9):519-20. PubMed ID: 12431384
[No Abstract] [Full Text] [Related]
11. The unexpected complexity of Fc gamma RIIB signal transduction.
Cambier JC; Fong D; Tamir I
Curr Top Microbiol Immunol; 1999; 244():43-55. PubMed ID: 10453648
[No Abstract] [Full Text] [Related]
12. What goes up must come down: the emerging spectrum of inhibitory receptors.
Yokoyama WM
J Exp Med; 1997 Dec; 186(11):1803-8. PubMed ID: 9417473
[No Abstract] [Full Text] [Related]
13. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
15. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.
Ono M; Bolland S; Tempst P; Ravetch JV
Nature; 1996 Sep; 383(6597):263-6. PubMed ID: 8805703
[TBL] [Abstract][Full Text] [Related]
16. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.
Scharenberg AM; El-Hillal O; Fruman DA; Beitz LO; Li Z; Lin S; Gout I; Cantley LC; Rawlings DJ; Kinet JP
EMBO J; 1998 Apr; 17(7):1961-72. PubMed ID: 9524119
[TBL] [Abstract][Full Text] [Related]
18. Negative signaling in health and disease.
Coggeshall KM
Immunol Res; 1999; 19(1):47-64. PubMed ID: 10374695
[TBL] [Abstract][Full Text] [Related]
19. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
20. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
